ZA

Zai Lab Ltd

  • CIK: 0001704292
  • EIN: 00-0000000
  • Business address: 4560 JINKE ROAD, BLDG. 1, 4F, PUDONG, SHANGHAI, China, 201210

Information

  • Mailing address
    4560 JINKE ROAD, BLDG. 1, 4F, PUDONG, SHANGHAI, Cayman Islands, 201210
  • Phone
    862161632588
  • State location
    China
  • State of incorporation
    Cayman Islands
  • Fiscal year end
    December 31
  • SIC
    2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
  • Filings
    N/A

About Zai Lab Ltd

Zai Lab Ltd (CIK: 0001704292) is an American company incorporated in the state of China. Head office is located at 4560 JINKE ROAD, BLDG. 1, 4F, PUDONG, SHANGHAI, China, 201210. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. Zai Lab Ltd is a public company and trade via Over-The-Counter (OTC).

Ownership

Owner Filings Transaction Date Type of Owner
Chen Yajing 0001985694 Aug-14-2023 officer: Chief Financial Officer
Vounatsos Michel 0001672709 Jan-07-2023 director
Amado Rafael 0001662119 Dec-30-2022 officer: See Remarks
Smiley Joshua L 0001725189 Aug-15-2022 officer: Chief Operating Officer
GAYNOR RICHARD 0001741284 Nov-19-2021 director
Morrison Scott W 0001662426 Oct-13-2021 director
WIRTH PETER 0001021041 Jan-01-2021 director
MOULDER LEON O JR 0001228865 Jan-01-2021 director
DIEKMAN JOHN D 0001240357 Jan-01-2021 director
Lis William 0001574558 Jan-01-2021 director
Qiming Venture Partners IV, L.P. 0001603597 Jan-01-2021 10 percent owner
Qiming Managing Directors Fund IV, L.P. 0001605610 Jan-01-2021 10 percent owner
Fu Tao 0001644888 Jan-01-2021 director, officer: President & COO
Du Ying 0001731790 Jan-01-2021 director, officer: Chairwoman & CEO
Edmondson Frazor Titus III 0001835780 Jan-01-2021 officer: Chief Legal Officer
Leung Nisa 0001835822 Jan-01-2021 director
Reinhart Harald 0001835824 Jan-01-2021 officer: Chief Medical Officer
Liang Yi 0001835832 Jan-01-2021 officer: CCO & President, Greater China
Cho William Ki Chul 0001835836 Jan-01-2021 officer: Chief Financial Officer
Sandler Alan B. 0001835966 Jan-01-2021 officer: Head of Global Dev., Oncology
Chen Kai-Xian 0001836195 Jan-01-2021 director
QM 11 Ltd 0001838417 Jan-01-2021 10 percent owner
Qiming GP IV, L.P. 0001838789 Jan-01-2021 10 percent owner
Qiming Corporate GP IV, Ltd 0001839126 Jan-01-2021 10 percent owner

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Zai Lab Ltd

Filings Format Description Filed/Effective File/Film Number
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000905148-25-000873 ( Act) Size: 0 KB		 Mar-06-2025

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000905148-25-000872 ( Act) Size: 0 KB		 Mar-06-2025

144 Document

Filing for proposed sale of securities under Rule 144

Acc-no: 0001959173-25-001720 (33 Act) Size: 0 KB		 Mar-05-2025

001-38205

25711081
144 Document

Filing for proposed sale of securities under Rule 144

Acc-no: 0001959173-25-001699 (33 Act) Size: 0 KB		 Mar-05-2025

001-38205

25709420
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000905148-25-000829 ( Act) Size: 0 KB		 Mar-04-2025

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000905148-25-000827 ( Act) Size: 0 KB		 Mar-04-2025

4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000905148-25-000826 ( Act) Size: 0 KB		 Mar-04-2025

144 Document

Filing for proposed sale of securities under Rule 144

Acc-no: 0001959173-25-001623 (33 Act) Size: 0 KB		 Mar-04-2025

001-38205

25702224
144 Document

Filing for proposed sale of securities under Rule 144

Acc-no: 0001959173-25-001515 (33 Act) Size: 0 KB		 Mar-03-2025

001-38205

25695383
144 Document

Filing for proposed sale of securities under Rule 144

Acc-no: 0001959173-25-001461 (33 Act) Size: 0 KB		 Feb-28-2025

001-38205

25687346
144 Document

Filing for proposed sale of securities under Rule 144

Acc-no: 0001959173-25-001459 (33 Act) Size: 0 KB		 Feb-28-2025

001-38205

25687329
144 Document

Filing for proposed sale of securities under Rule 144

Acc-no: 0001959173-25-001447 (33 Act) Size: 0 KB		 Feb-28-2025

001-38205

25684428
10-K Document

Annual report pursuant to section 13 and 15(d)

Acc-no: 0001628280-25-008409 (34 Act) Size: KB		 Feb-27-2025

001-38205

25672652
8-K Document

Current report filing

Acc-no: 0001628280-25-008406 (34 Act) Size: KB		 Feb-27-2025

001-38205

25672632
SCHEDULE 13G/A Document Acc-no: 0001274173-25-000084 (34 Act) Size: KB Feb-14-2025

005-90351

25625760
SCHEDULE 13G Document Acc-no: 0000315066-25-000820 (34 Act) Size: KB Feb-12-2025

005-90351

25612493
SCHEDULE 13G/A Document Acc-no: 0000902219-25-000039 (34 Act) Size: KB Feb-10-2025

005-90351

25604180
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000905148-25-000014 ( Act) Size: 0 KB		 Jan-03-2025

8-K Document

Current report filing

Acc-no: 0001628280-25-000261 (34 Act) Size: KB		 Jan-03-2025

001-38205

25506468
4 Document

Statement of changes in beneficial ownership of securities

Acc-no: 0000905148-25-000011 ( Act) Size: 0 KB		 Jan-02-2025

Recent 20 filings. View all Zai Lab Ltd filings

Reviews

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Frequently Asked Questions

Tags:

  • Zai Lab Ltd overview
  • Zai Lab Ltd job
  • Zai Lab Ltd stock
  • Zai Lab Ltd ownership
  • Zai Lab Ltd CEO
  • Zai Lab Ltd documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

atai Life Sciences Luxembourg S.A.
Update: Sep 23, 2025
Hyperliquid Strategies Inc
Update: Sep 05, 2025
Polaryx Therapeutics, Inc.
Update: Sep 05, 2025
Nasus Pharma Ltd
Update: Jul 10, 2025
Promicell, Inc.
Update: May 30, 2025
Maius Pharmaceutical Group Co., Ltd.
Update: Mar 01, 2025

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 3844 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 3105 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 4769 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 4408 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 4749 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 2406 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 3537 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 1697 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 3927 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by